Skip to main content

Antimicrobial Resistance & Stewardship

  • May 31, 2023

    Mitigating Global Disparities in the Fight Against Antimicrobial Resistance

    Antibiotics have been used to save countless lives for decades. What happens when these drugs we depend on are no longer effective? Imagine a scenario where routine surgeries and minor infections can frequently become life-threatening, and the cost of treatment increases substantially.
  • May 08, 2023

    The Global Point Prevalence Survey: making the Difference in the Fight Against Antimicrobial Resistance

    The Global Point Prevalence Survey (Global-PPS) is a free, online tool, developed by the University of Antwerp in Belgium, to measure and monitor antimicrobial prescribing and resistance in hospitals worldwide. Since its creation and launched in 2015, more than 90 countries have taken part in the initiative, involving 1,300 hospitals and 500,000 patients.
  • February 15, 2023

    Transferable patent extensions

    A failure of the antibiotics market is hampering vital innovation in this field. Researchers from the Toulouse School of Economics (TSE) propose a new mechanism for compensating innovation, taking the form of a voucher that would be transferable.
  • November 22, 2022

    Fleming Fund Supports Global AMR Surveillance Network

    Since 2019, bioMérieux has partnered with the Fleming Fund to provide high medical value diagnostic solutions, innovative data analytics tools and antimicrobial susceptibility testing in 15 countries located in the Africa and Asia Pacific regions.
  • October 20, 2022

    We can’t rely on development of new drugs alone to combat antimicrobial resistance

    While the majority of major drug companies have been scaling back or cutting antibiotic research, diagnostics and advanced data analytics can help preserve existing treatments for patients.